Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
Nervous sentiment around Seagate and the storage sector
Arm Holdings under regulatory pressure!
US Open: Waiting Mode Ahead of Nvidia Report
Market Wrap: Energy Makes a Comeback⚡Investors Fear a New Escalation in the Middle East💥